Tirzepatide at 10 and 15 mg doses produces significantly greater weight loss than semaglutide 2.4 mg in people without type 2 diabetes, with tirzepatide users losing 5 to 6.5 kg more over 68 to 72 weeks. According to Gram Research analysis of this 2026 indirect treatment comparison, tirzepatide also improved body composition, blood pressure, and cholesterol levels more effectively, while maintaining similar safety profiles to semaglutide.
A new study compared two popular weight-loss medications: tirzepatide and semaglutide. Researchers looked at how well each drug worked for people who are overweight or obese but don’t have type 2 diabetes. According to Gram Research analysis, tirzepatide at higher doses helped people lose more weight, improved their body composition, and lowered blood pressure more effectively than semaglutide. Both medications were safe and well-tolerated. The findings suggest tirzepatide may be a stronger option for some patients seeking weight loss treatment.
Key Statistics
A 2026 indirect treatment comparison found that tirzepatide 15 mg produced 6.5 kg more weight loss than semaglutide 2.4 mg over 72 weeks in adults with obesity or overweight without type 2 diabetes.
Tirzepatide 10 and 15 mg doses lowered diastolic blood pressure by 1.9 to 2.4 mmHg more than semaglutide in a 2026 study of weight-loss medications.
In a 2026 analysis, tirzepatide 15 mg reduced body fat percentage by 3.5 percent and increased lean muscle mass by 3.4 percent compared to semaglutide in participants with obesity.
Tirzepatide at all three doses (5, 10, and 15 mg) raised HDL cholesterol by 3.8 to 5.4 percent more than semaglutide 2.4 mg according to a 2026 treatment comparison study.
The Quick Take
- What they studied: How well tirzepatide and semaglutide work for weight loss in people without diabetes
- Who participated: Adults with obesity (BMI of 30 or higher) or overweight (BMI of 27 or higher) with at least one weight-related health problem, but without type 2 diabetes
- Key finding: Tirzepatide at 10 and 15 mg doses helped people lose 5 to 6.5 kg more weight than semaglutide over about 68 to 72 weeks
- What it means for you: If you’re considering weight-loss medication, tirzepatide may offer stronger results than semaglutide, though both are safe options. Talk to your doctor about which is right for your situation
The Research Details
This study used a method called indirect treatment comparison, which means researchers didn’t directly test tirzepatide against semaglutide in the same trial. Instead, they looked at results from two separate studies where each drug was compared to a placebo (a fake medication). By analyzing how each drug performed against the placebo, researchers could estimate how they would compare to each other.
The study included adults with obesity or overweight who had at least one weight-related health problem, such as high blood pressure or high cholesterol. Participants were not allowed to have type 2 diabetes. They received either tirzepatide (at doses of 5, 10, or 15 mg per week) or semaglutide (2.4 mg per week), along with a reduced-calorie diet and exercise program.
Researchers measured weight loss, body composition (how much fat versus muscle), blood pressure, cholesterol, and blood sugar levels. They followed participants for about 68 to 72 weeks to see the long-term effects.
This approach allows researchers to compare medications from different studies fairly by using statistical adjustments. It’s faster and less expensive than running a new head-to-head trial, and it helps doctors and patients understand which medication might work better for their specific needs.
The study used data from well-designed clinical trials and adjusted results for differences between participants, such as sex and ethnicity. However, because this is an indirect comparison rather than a direct head-to-head trial, the results are estimates rather than direct measurements. The findings are most reliable for the higher doses of tirzepatide (10 and 15 mg), where differences were statistically significant
What the Results Show
Tirzepatide at the 10 and 15 mg doses outperformed semaglutide in weight loss. People taking tirzepatide 10 mg lost about 5.1 kg more than those on semaglutide, while those on tirzepatide 15 mg lost about 6.5 kg more. More people achieved significant weight loss milestones (losing at least 10, 15, or 20 percent of their body weight) with the higher tirzepatide doses.
Beyond weight loss, tirzepatide showed additional benefits. All three doses of tirzepatide lowered diastolic blood pressure (the bottom number in a blood pressure reading) more than semaglutide did. Tirzepatide also raised HDL cholesterol (the good kind) more effectively. Blood sugar control improved slightly more with tirzepatide, though both drugs had modest effects since participants didn’t have diabetes.
For body composition, tirzepatide 15 mg made a meaningful difference. People lost more fat mass and gained more lean muscle mass compared to semaglutide users. This matters because losing fat while preserving muscle is healthier than losing weight through muscle loss alone.
The lower dose of tirzepatide (5 mg) showed trends toward better results than semaglutide, but the differences weren’t statistically significant, meaning they could have occurred by chance.
Both medications were well-tolerated with similar safety profiles. Gastrointestinal side effects, which are common with these drugs, occurred at comparable rates. No unexpected safety concerns emerged with tirzepatide. The improvements in blood pressure and cholesterol suggest these medications benefit heart health beyond just weight loss.
This research aligns with earlier studies showing that tirzepatide is a newer, more potent medication than semaglutide. Tirzepatide works on two hormone pathways instead of one, which may explain its stronger effects. The findings support growing evidence that tirzepatide represents an advancement in weight-loss treatment options.
This study compared medications indirectly rather than in a head-to-head trial, so results are estimates based on statistical modeling. The study only included people without type 2 diabetes, so results may not apply to diabetic patients. The exact sample sizes from the original trials weren’t specified in this analysis. Results may vary based on individual factors like age, genetics, and lifestyle adherence
The Bottom Line
For people seeking weight-loss medication without diabetes, tirzepatide at 10 or 15 mg doses appears more effective than semaglutide 2.4 mg. High confidence in this finding for weight loss and body composition. Moderate confidence in additional cardiovascular benefits. Both medications work best when combined with diet and exercise. Consult your doctor to determine which medication suits your health profile and goals
Adults with obesity or overweight with weight-related health problems who are considering medication. People currently taking semaglutide who aren’t seeing desired results. Healthcare providers choosing between these medications for patients. People interested in understanding the latest weight-loss treatment options. This study does not apply to people with type 2 diabetes, who may have different treatment considerations
Weight loss typically becomes noticeable within 4 to 8 weeks. Significant improvements in body composition and blood pressure take 12 to 16 weeks. Maximum benefits appear around 68 to 72 weeks (about 1.5 years) based on this study. Results depend on consistent medication use, diet adherence, and physical activity
Frequently Asked Questions
Is tirzepatide better than semaglutide for weight loss?
For people without diabetes, tirzepatide at 10 and 15 mg doses produces more weight loss than semaglutide 2.4 mg, with differences of 5 to 6.5 kg over 72 weeks. Both medications are safe, but tirzepatide appears more potent for weight reduction and body composition changes.
How much weight can you lose with tirzepatide versus semaglutide?
Tirzepatide 15 mg helped people lose approximately 6.5 kg more than semaglutide over 72 weeks when combined with diet and exercise. Individual results vary based on starting weight, adherence, and lifestyle factors.
What are the side effects of tirzepatide compared to semaglutide?
Both medications have similar safety profiles with comparable side effect rates. Gastrointestinal issues like nausea are common with both drugs. No unexpected safety concerns emerged with tirzepatide in this analysis.
Can tirzepatide help with blood pressure and cholesterol?
Yes, tirzepatide lowered diastolic blood pressure by 1.9 to 2.4 mmHg more than semaglutide and raised beneficial HDL cholesterol by 3.8 to 5.4 percent, suggesting cardiovascular benefits beyond weight loss.
Who should use tirzepatide instead of semaglutide?
People without type 2 diabetes seeking maximum weight loss and body composition improvements may benefit more from tirzepatide, especially at 10 or 15 mg doses. Discuss with your doctor to determine the best option for your health goals and medical history.
Want to Apply This Research?
- Log weekly weight, waist circumference, and energy levels. Track medication doses and any side effects. Monitor blood pressure if you have a home device. Record diet adherence and exercise minutes to correlate with weight changes
- Set a weekly weigh-in day and log results in the app. Create meal plans within your calorie target. Schedule 150 minutes of weekly physical activity and mark completed sessions. Use app reminders for medication doses to ensure consistency
- Review monthly trends rather than daily fluctuations. Compare measurements every 4 weeks to track progress toward 10, 15, and 20 percent weight-loss milestones. Share app data with your doctor at regular checkups. Adjust diet and exercise based on app insights and medical guidance
This research compares two prescription weight-loss medications and should not be interpreted as medical advice. Tirzepatide and semaglutide are prescription drugs that require a doctor’s evaluation and monitoring. This study applies only to adults without type 2 diabetes. Individual results vary based on genetics, lifestyle, and adherence. Consult your healthcare provider before starting, stopping, or switching weight-loss medications. This article summarizes research findings and does not replace professional medical guidance.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.